We showed in the present study that metformin suppressed growth of mesothelioma in a p53-independent manner and firstly reported to our knowledge that a combinatory use of metformin and nutlin-3a produced additive or synergistic inhibitory effects. This evidence concerns the gene TP53 and mesothelioma.